Since 2008, GoeGoe Honglin Pharm. has successively established university-enterprise cooperation with Indiana University (USA) and Shenyang Pharmaceutical University, creating dedicated internship and practice bases for students from both institutions to provide hands-on platforms for pharmaceutical talent development.
Built on a shared commitment to quality, we have established trademark licensing and brand strategic partnerships with leading enterprises such as Sanjiu Medical & Pharmaceutical, Sunflower Pharmaceutical, Fujian Xinzijin Pharmaceutical, and Guoda Drugstore. By leveraging each other's strengths and deep industry experience, we jointly develop high-quality products that meet consumer needs.
On March 24, 2021, executives of China Resources Pharmaceutical Commercial Group Co., Ltd. visited GoeGoe Honglin Pharm.. The delegation toured advanced technical facilities and R&D laboratories, sought future strategic cooperation opportunities, and pledged to jointly advance the development of China’s pharmaceutical industry.
In December 2022, we were designated as a Beijing Municipal Epidemic Prevention Supply Assurance Enterprise. We made every effort to ensure 24-hour production of two key anti-epidemic drugs: JUPOPHON® Ibuprofen Sustained-Release Capsules and JUPOTAC® Paracetamol, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Tablets II / Paracetamol, Pseudoephedrine Hydrochloride, Diphenhydramine Hydrochloride and Dextromethorphan Hydrobromide Tablets, so as to guarantee sufficient supply and stable prices in Beijing.
After rigorous screening and comprehensive evaluation, Xi’an-Janssen Pharmaceutical Ltd. (now Johnson & Johnson Innovative Medicine China) ultimately confirmed the core advantages of GoeGoe Honglin Pharm.'s “HOWELT®” Famotidine, Calcium Carbonate and Magnesium Hydroxide Chewable Tablets in terms of curative effect stability, quality control, and market application value.